Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigm

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Diffuse alveolar hemorrhage (DAH) is a clinical syndrome with typical symptoms dyspnea and hemoptysis. DAH is a complication of specific diseases, in some cases with acute catastrophic hemoptysis, while other patients present low grade alveolar bleeding with a need of chronic transfusion as in pulmonary hemosiderosis.
Original languageEnglish
JournalBiologics (Online)
Volume6
Pages (from-to)37-46
Number of pages10
ISSN1177-5491
DOIs
Publication statusPublished - 2012

ID: 36526919